Use of Antithrombotic Therapy for Secondary Prevention in Patients with Stable Atherosclerotic Cardiovascular Disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) Study.

Sanam Verma,Shaun G Goodman,Mary K Tan,Benoit Daneault, Bruce J Lubelsky,Samer Mansour,Andy S Lam,David Laflamme,Wayne J Tymchak,Robert C Welsh, Randi C Rose, Rajendra M Chetty,Christian M Constance,Tomas Cieza,Brian J Potter,Michael C Hartleib,Razi Khan,Richard F Choi, William Keeble,Jean-Pierre Dery, Dinkar Shukla,Grace L Chua,Kevin R Bainey

International journal of clinical practice（2021）

引用 2|浏览5

暂无评分

摘要

In contemporary Canadian clinical practice of stable ASCVD patients, a large number of patients receive antithrombotic therapy other than SAPT. Further efforts are required to guide the appropriate selection of patients in whom more potent antithrombotic therapies may safely reduce residual risk.

查看译文

关键词

anti-platelets,atherosclerotic cardiovascular disease,oral anticoagulation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要